Editor's note: This article is the final installment of a 3-part series. Please be sure to check out Part 1 and Part 2, which were published earlier this morning!


Continuation of the "What Went Wrong?" checklist:

7. Merger and acquisition activity peaked with the dinging of the Sprint (PCS Quote) deal. This collapse, coupled with the earnings disappointment for WorldCom(WCOM Quote), meant an end to the mass consolidation in the sector. Smaller players can still get bids, but the larger players won't get gobbled so fast. I think this will get better in the fall if Bush wins, because I can imagine that guy dismantling antitrust.

8. Short-term rate-rise expectations crushed the financials. This group had been humming, with many of its players hitting 52-week highs. Wachovia's (WB Quote) nasty blowup took care of the 52-week high fever, and possible rate increases kiboshed anything else that could happen positively. I think the negatives here are well-discounted, but I am not running out to buy the group.

9. Pfizer(PFE Quote), which had become the leader of a resurgent drug group, blew the quarter. This was a terrible blow to drug investors who had begun to think that Pfizer had regained the luster it had a couple of years ago. Merger savings don't seem to stanch the bleeding here. Lilly (LLY Quote) can't do what Pfizer could.

10. Philip Morris (MO Quote) lost the big case that had been holding it back. A win in this class-action case in Florida would have kept the food group, another leader, cooking well into the fall. Instead, the biggest-cap in the business lost its footing. I think this stock comes back, but it doesn't have any momentum.

There's your checklist. Lots of stuff went wrong. Some of it can be undone, most can't. Which is why we aren't going anywhere anytime soon. We will bounce around with 3% gains and 4% drops, mixed with 4% gains and 3% drops as we get closer to NDX 3300. Boring, range-bound, frustrating. Get used to it. It will be like that for some time.


Hurry! Time is running out to see James J. Cramer live in New York City on August 7, 2000. Click here for details: http://www.bigfishinc.com/cramerlive
James J. Cramer is manager of a hedge fund and co-founder of TheStreet.com. At time of publication, his fund was long Philip Morris. His fund often buys and sells securities that are the subject of his columns, both before and after the columns are published, and the positions that his fund takes may change at any time. Under no circumstances does the information in this column represent a recommendation to buy or sell stocks. Cramer's writings provide insights into the dynamics of money management and are not a solicitation for transactions. While he cannot provide investment advice or recommendations, he invites you to comment on his column at jjcletters@thestreet.com.
Your Recent Quotes: Quote Up0 | Quote Down0
 
Dow S&P 500 NASDAQ
Oil*
63.92
8,278.09
892.86
1,777.74
10 Yr
3.51%
2.65
3.56
18.78
-0.03%
-0.40%
-1.05%
Data delayed 20 min
Get Jim Cramer's Free Newsletter

The Daily Booyah!
Get your daily dose of Cramer in your inbox.
Submit
We respect your privacy.

Premium Stock Ideas
Access Action Alerts Plus to find out Cramer's latest picks now!

Brokerage Partners